Drug profile · INN
trifarotene
AKLIEF
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
trifarotene (AKLIEF) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
Key facts
Frequently asked questions
What is trifarotene?
trifarotene (AKLIEF) is an FDA-listed pharmaceutical active ingredient. Route of administration: topical. Current US regulatory status: approved.
What is the brand name for trifarotene?
AKLIEF is a marketed brand name for trifarotene. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of trifarotene?
trifarotene has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.